LQLei Qiao

Lei Qiao

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lei Qiao has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Cheng Zhang

    State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, China

    1 shared publication
  • Chungang Zhai

    State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China

    1 shared publication
  • Dan Xu

    State Key Laboratory for Innovation and Transformation of Luobing Theory; Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province; Department of Cardiology, Qilu Hospital of Shandong University, Jinan, China, 250012; Department of General Practice, Qilu Hospital of Shandong University, Jinan, China

    1 shared publication
  • Guang Zhang

    Department of Health Management, Shandong Engineering Research Center of Health Management, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Shandong Institute of Health Management, Jinan, People’s Republic of China

    1 shared publication
  • Huixia Lu

    State Key Laboratory for Innovation and Transformation of Luobing Theory, Key Laboratory of Cardiovascular Remodeling and Function Research of MOE, NHC, CAMS and Shandong Province, Department of Cardiology, Qilu Hospital of Shandong University, China

    1 shared publication
  • Jing Ma

    The Key Laboratory of Cardiovascular Remodeling and Function Research, Chinese Ministry of Education, Chinese National Health Commission and Chinese Academy of Medical Sciences, The State and Shandong Province Joint Key Laboratory of Translational Cardiovascular Medicine, Department of Cardiology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China (L.Q., J.M., Z.Z., W.S., C.Z., D.X., Z.W., H.L., M.Z., W.C., Y.Z.).

    1 shared publication

Latest Publications

  • Open Access

    Association between circulating selenium levels and arterial stiffness: a nationwide cross-sectional study

    by Kunsheng Zhao, Lei Qiao, Wenqi Hu, Wenhai Sui, Xiuchang Li, Guang Zhang

    Background: Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Arterial stiffness is an important pathological characteristic of ASCVD. Selenium (Se) may have a notable effect of arterial stiffness. However, the relationship between circulating Se (CSe) levels and arterial stiffness remains unclear. Methods: A total of 11 937 participants from the National Health and Nutrition Examination Survey (NHANES) from 2011 to 2018 were enrolled. The relationship between CSe levels, estimated pulse wave velocity (ePWV), and the atherogenic index of plasma (AIP) was evaluated using univariate and multivariate linear regression, dose-response, and mediation analyses. Results: A linear relationship between the CSe index and high AIP ( P for nonlinearity = 0.1) and a U-shaped relationship between the CSe index and high ePWV were found ( P for nonlinearity < 0.001). In fully adjusted models, the relationship between CSe and high AIP was positive (OR = 1.48, 95% CI: 1.20, 1.82; P = 0.001). An inflection point was found in the relationship between the CSe index and high ePWV. CSe levels of < 2.99 μmol/L were negatively related to high ePWV (OR = 0.71; 95% CI: 0.59, 0.86; P < 0.001). In contrast, CSe levels of ≥ 2.99 μmol/L were positively related to high ePWV (OR = 2.66; 95% CI: 1.66, 4.25; P < 0.001). Furthermore, the indirect effect mediated by the sex of CSe on high AIP was prominent (indirect effect = 0.006; 95% CI: 0.003, 0.008; percent mediation = 26.49%) in the fully adjusted models. Conclusions: Our findings suggests a significant relationship between CSe levels and arterial stiffness, the mechanism behind which should be further explored.


  • Open Access

    Deficient Chaperone-Mediated Autophagy Promotes Inflammation and Atherosclerosis

    by Lei Qiao, Jing Ma, Zihao Zhang, Wenhai Sui, Chungang Zhai, Dan Xu, Zunzhe Wang, Huixia Lu, Meng Zhang, Cheng Zhang, et al.

    Rationale: The NLRP3 (NLR [NOD-like receptor] family, pyrin domain containing 3) inflammasome is an important driver of atherosclerosis. Our previous study shows that chaperone-mediated autophagy (CMA), one of the main lysosomal degradative process, has a regulatory role in lipid metabolism of macrophages. However, whether the NLRP3 inflammasome is regulated by CMA, and the role of CMA in atherosclerosis remains unclear. Objective: To determine the role of CMA in the regulation of NLRP3 inflammasome and atherosclerosis. Methods and Results: The expression of CMA marker, LAMP-2A (lysosome-associated membrane protein type 2A), was first analyzed in ApoE −/− mouse aortas and human coronary atherosclerotic plaques, and a significant downregulation of LAMP-2A in advanced atherosclerosis in both mice and humans was observed. To selectively block CMA, we generated macrophage-specific conditional LAMP-2A knockout mouse strains in C57BL/6 mice and ApoE −/− mice. Deletion of macrophage LAMP-2A accelerated atherosclerotic lesion formation in the aortic root and the whole aorta in ApoE −/− mice. Mechanistically, LAMP-2A deficiency promoted NLRP3 inflammasome activation and subsequent release of mature IL (interleukin)-1β in macrophages and atherosclerotic plaques. Furthermore, gain-of-function studies verified that restoration of LAMP-2A levels in LAMP-2A–deficient macrophages greatly attenuated NLRP3 inflammasome activation. Importantly, we identified the NLRP3 protein as a CMA substrate and demonstrated that LAMP-2A deficiency did not affect the NLRP3 mRNA levels but hindered degradation of the NLRP3 protein through CMA pathway. Conclusions: CMA function becomes impaired during the progression of atherosclerosis, which increases NLRP3 inflammasome activation and secretion of IL-1β, promoting vascular inflammation and atherosclerosis progression. Our study unveils a new mechanism by which NLRP3 inflammasome is regulated in macrophages and atherosclerosis, thus providing a new insight into the role of autophagy-lysosomal pathway in atherosclerosis. Pharmacological activation of CMA may provide a novel therapeutic strategy for atherosclerosis and other NLRP3 inflammasome/IL-1β–driven diseases.